GB0206031D0 - Inhibitors - Google Patents

Inhibitors

Info

Publication number
GB0206031D0
GB0206031D0 GB0206031A GB0206031A GB0206031D0 GB 0206031 D0 GB0206031 D0 GB 0206031D0 GB 0206031 A GB0206031 A GB 0206031A GB 0206031 A GB0206031 A GB 0206031A GB 0206031 D0 GB0206031 D0 GB 0206031D0
Authority
GB
United Kingdom
Prior art keywords
inhibitors
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0206031A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alizyme Therapeutics Ltd
Original Assignee
Alizyme Therapeutics Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alizyme Therapeutics Ltd filed Critical Alizyme Therapeutics Ltd
Priority to GB0206031A priority Critical patent/GB0206031D0/en
Publication of GB0206031D0 publication Critical patent/GB0206031D0/en
Priority to PCT/GB2002/003903 priority patent/WO2003020282A1/en
Priority to HU0401298A priority patent/HUP0401298A3/en
Priority to CN028185900A priority patent/CN1556706B/en
Priority to PL02368994A priority patent/PL368994A1/en
Priority to NZ531272A priority patent/NZ531272A/en
Priority to EP02755241A priority patent/EP1446125B1/en
Priority to US10/488,045 priority patent/US7407954B2/en
Priority to JP2003524589A priority patent/JP2005527469A/en
Priority to AT02755241T priority patent/ATE429918T1/en
Priority to KR1020047002805A priority patent/KR100934256B1/en
Priority to RU2004109588/04A priority patent/RU2324696C2/en
Priority to MXPA04001922A priority patent/MXPA04001922A/en
Priority to CA002458213A priority patent/CA2458213A1/en
Priority to AU2002321536A priority patent/AU2002321536B2/en
Priority to DE60232170T priority patent/DE60232170D1/en
Priority to MYPI20023211A priority patent/MY139608A/en
Priority to ARP020103295A priority patent/AR036399A1/en
Priority to ZA2004/01595A priority patent/ZA200401595B/en
Priority to NO20041295A priority patent/NO20041295L/en
Priority to HK04107740.4A priority patent/HK1064940A1/en
Priority to US12/178,920 priority patent/US20090029978A1/en
Priority to JP2010019160A priority patent/JP2010159260A/en
Ceased legal-status Critical Current

Links

GB0206031A 2001-08-30 2002-03-14 Inhibitors Ceased GB0206031D0 (en)

Priority Applications (23)

Application Number Priority Date Filing Date Title
GB0206031A GB0206031D0 (en) 2002-03-14 2002-03-14 Inhibitors
DE60232170T DE60232170D1 (en) 2001-08-30 2002-08-23 THIENO- (1,3) -OXAZINE-4-ONE WITH LIPASE INHIBIVING EFFECT
KR1020047002805A KR100934256B1 (en) 2001-08-30 2002-08-23 Thieno (1,3) oxazin-4-one with lipase inhibitory activity
MXPA04001922A MXPA04001922A (en) 2001-08-30 2002-08-23 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity.
CN028185900A CN1556706B (en) 2001-08-30 2002-08-23 Thieno [1,3] oxazin-4-ones with lipase inhibiting activity
PL02368994A PL368994A1 (en) 2001-08-30 2002-08-23 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity
NZ531272A NZ531272A (en) 2001-08-30 2002-08-23 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity
EP02755241A EP1446125B1 (en) 2001-08-30 2002-08-23 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity
US10/488,045 US7407954B2 (en) 2001-08-30 2002-08-23 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity
JP2003524589A JP2005527469A (en) 2001-08-30 2002-08-23 Thieno- (1,3) -oxazin-4-ones with lipase inhibitory activity
AT02755241T ATE429918T1 (en) 2001-08-30 2002-08-23 THIENO-(1,3)-OXAZIN-4-ONE WITH LIPASE INHIBITING EFFECT
PCT/GB2002/003903 WO2003020282A1 (en) 2001-08-30 2002-08-23 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity
RU2004109588/04A RU2324696C2 (en) 2001-08-30 2002-08-23 Thieno-(1,3)-oxazine-4-ons possessing inhibiting activity in respect to lipase
HU0401298A HUP0401298A3 (en) 2001-08-30 2002-08-23 Thieno [1,3] oxazin-4-ones with lipase inhibiting activity, process for their preparation and pharmaceutical compositions containing them
CA002458213A CA2458213A1 (en) 2001-08-30 2002-08-23 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity
AU2002321536A AU2002321536B2 (en) 2001-08-30 2002-08-23 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity
MYPI20023211A MY139608A (en) 2001-08-30 2002-08-29 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity
ARP020103295A AR036399A1 (en) 2001-08-30 2002-08-30 USE OF TIENO-OXAZINONE COMPOUNDS FOR THE PREPARATION OF A MEDICINAL PRODUCT FOR THE PREVENTION AND TREATMENT OF OBESITY AND OTHER USES, TENO-OXAZINONE COMPOUNDS, A PREPARATION PROCESS, A PHARMACEUTICAL COMPOSITION, AND A UNDERLY COSMETIC METHOD OF MAINTENANCE.
ZA2004/01595A ZA200401595B (en) 2001-08-30 2004-02-25 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity
NO20041295A NO20041295L (en) 2001-08-30 2004-03-29 Tieno (1,3) oxazin-4-ones with lipase inhibitory activity
HK04107740.4A HK1064940A1 (en) 2001-08-30 2004-10-07 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity
US12/178,920 US20090029978A1 (en) 2001-08-30 2008-07-24 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity
JP2010019160A JP2010159260A (en) 2001-08-30 2010-01-29 Thieno-(1,3)-oxazin-4-ones with lipase inhibiting activity

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0206031A GB0206031D0 (en) 2002-03-14 2002-03-14 Inhibitors

Publications (1)

Publication Number Publication Date
GB0206031D0 true GB0206031D0 (en) 2002-04-24

Family

ID=9932973

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0206031A Ceased GB0206031D0 (en) 2001-08-30 2002-03-14 Inhibitors

Country Status (1)

Country Link
GB (1) GB0206031D0 (en)

Similar Documents

Publication Publication Date Title
EG25482A (en) Inhibitors
PL373649A1 (en) Kinase inhibitors
AU2003202263A1 (en) Roh-kinase inhibitors
SI1569907T1 (en) Nicotinamide-based kinase inhibitors
AU2003300832A8 (en) Nf-kappab inhibitors
EP1499336A4 (en) Protease inhibitors
EP1558609A4 (en) Kinase inhibitors
EP1532133A4 (en) Nf-:b inhibitors
GB2412372B (en) Pyrazine-based tubulin inhibitors
AU2003230392A8 (en) Beta-secretase inhibitors
EP1570847A4 (en) Phosphodiesterase 10a inhibitors
EP1569907A4 (en) Nicotinamide-based kinase inhibitors
AU2003299901A8 (en) Thrombin inhibitors
AU2003269984A8 (en) Protease inhibitors
AU2003224941A8 (en) Nf-kappab inhibitors
AU2003263738A8 (en) Protease inhibitors
AU2003232362A8 (en) 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors
AU2003233642A8 (en) Protease inhibitors
AU2003304496A8 (en) Protease inhibitors
GB0206031D0 (en) Inhibitors
GB0217330D0 (en) Inhibitors
GB0208094D0 (en) Inhibitors
GB0207488D0 (en) Inhibitors
GB0226149D0 (en) Inhibitors
GB0224102D0 (en) Inhibitors

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)